Article
Genetic variability in CYP2A6 and the pharmacokinetics of nicotine.
Pharmacogenomics - 1 Oct 2007
Mwenifumbo Jill C, Tyndale Rachel F
Abstract excerpt
Nicotine is the psychoactive substance responsible for tobacco dependence. It is also a therapeutic used to aid smoking cessation. Cytochrome P450 (CYP)2A6 is the human hepatic enzyme that mediates most of nicotine's metabolic inactivation to cotinine. Genetic variation in the CYP2A6 gene can increase or decrease enzyme activity through altering the protein's expression level or its structure and function. This...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
